WO2025008759 - POLYMERIC LEUPROLIDE ACETATE FORMULATIONS
National phase entry:
Publication Number
WO/2025/008759
Publication Date
09.01.2025
International Application No.
PCT/IB2024/056487
International Filing Date
03.07.2024
Title **
[English]
POLYMERIC LEUPROLIDE ACETATE FORMULATIONS
[French]
FORMULATIONS POLYMÈRES D'ACÉTATE DE LEUPROLIDE
Applicants **
TOLMAR INTERNATIONAL LIMITED
10 Earlsfort Terrace
Dublin 2, D02 T380, IE
Inventors
JANAGAM, Dileep
68 Springhaven Ct.
San Ramon, California 94583, US
DUMMER, David
12525 Lake Terrace Lane
Firestone, Colorado 80504, US
KAUFFMAN, Travis
100 1st Street
Fort Collins, Colorado 80524, US
MIDDLETON, John
4920 McMurry Ave.
Unit D-1
Fort Collins, Colorado 80525, US
VAN HOVE, Amy
2702 Annelise Way
Fort Collins, Colorado 80525, US
MARQUARDT, Nicole
3137 Birmingham Drive
Fort Collins, Colorado 80526, US
DEWEERD, Nicholas
6957 Rosemont Court
Fort Collins, Colorado 80525, US
JOHNSON, Erik Cullen
2512 W. Stuart Street
Fort Collins, Colorado 80526, US
Priority Data
63/512,016
05.07.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1995 | |
| EPO | Filing, Examination | 12210 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 6710 |
Total: 22081 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Liquid-liquid polymer leuprolide acetate (LA) formulations comprising a biodegradable polymer and biocompatible solvent, and methods of using the formulations.[French]
L'invention concerne des formulations d'acétate de leuprolide (LA) polymère liquide-liquide comprenant un polymère biodégradable et un solvant biocompatible, et des procédés d'utilisation des formulations.